UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 148

Sortiert nach

A study of over 35,000 women with breast cancer tested with a 25‐gene panel of hereditary cancer genes

Cancer, 2017-05, Vol.123 (10), p.1721-1730

2017

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of Variant Reclassification Following Hereditary Cancer Genetic Testing

JAMA : the journal of the American Medical Association, 2018-09, Vol.320 (12), p.1266

2018

Link zum Volltext

Verfügbarkeit prüfen

Impact of pharmacogenomics on clinical outcomes in major depressive disorder in the GUIDED trial: A large, patient- and rater-blinded, randomized, controlled study

Journal of psychiatric research, 2019-04, Vol.111, p.59-67

2019

Link zum Volltext

Verfügbarkeit prüfen

An independent validation of a gene expression signature to differentiate malignant melanoma from benign melanocytic nevi

Cancer, 2017-02, Vol.123 (4), p.617-628

2017

Link zum Volltext

Verfügbarkeit prüfen

Lipid Flip-Flop in Binary Membranes Composed of Phosphatidylserine and Phosphatidylcholine

The journal of physical chemistry. B, 2013-12, Vol.117 (48), p.15041-15050

2013

Link zum Volltext

Verfügbarkeit prüfen

Phosphatidylglycerol Flip-Flop Suppression due to Headgroup Charge Repulsion

The journal of physical chemistry. B, 2015-08, Vol.119 (32), p.10252-10260

2015

Link zum Volltext

Verfügbarkeit prüfen

Electrostatic Induction of Lipid Asymmetry

Journal of the American Chemical Society, 2011-06, Vol.133 (23), p.8794-8797

2011

Link zum Volltext

Verfügbarkeit prüfen

Phospholipid flip-flop modulated by transmembrane peptides WALP and melittin

Journal of structural biology, 2009-10, Vol.168 (1), p.37-52

2009

Link zum Volltext

Verfügbarkeit prüfen

The effect of cholesterol on the intrinsic rate of lipid flip-flop as measured by sum-frequency vibrational spectroscopy

Faraday discussions, 2013-01, Vol.161, p.45-61

2013

Link zum Volltext

Verfügbarkeit prüfen

Phase II neoadjuvant clinical trial of carboplatin and eribulin in women with triple negative early-stage breast cancer (NCT01372579)

Breast cancer research and treatment, 2015-06, Vol.151 (3), p.629-638

2015

Link zum Volltext

Verfügbarkeit prüfen

Age of ovarian cancer diagnosis among BRIP1, RAD51C, and RAD51D mutation carriers identified through multi-gene panel testing

Journal of ovarian research, 2021-04, Vol.14 (1), p.61-61, Article 61

2021

Link zum Volltext

Verfügbarkeit prüfen

Impact of a genetic counseling requirement prior to genetic testing

BMC health services research, 2018-03, Vol.18 (1), p.165-165, Article 165

2018

Link zum Volltext

Verfügbarkeit prüfen

Detection of somatic variants in peripheral blood lymphocytes using a next generation sequencing multigene pan cancer panel

Cancer genetics, 2017-02, Vol.211, p.5-8

2017

Link zum Volltext

Verfügbarkeit prüfen

Detection of large rearrangements in a hereditary pan-cancer panel using next-generation sequencing

BMC medical genomics, 2019-10, Vol.12 (1), p.138-9, Article 138

2019

Link zum Volltext

Verfügbarkeit prüfen

Lynch Syndrome Patients with Limited Family History Identified in a Laboratory Setting: A Descriptive Study

Oncology, 2015-01, Vol.89 (4), p.221-226

2015

Link zum Volltext

Verfügbarkeit prüfen

Identification of pathogenic retrotransposon insertions in cancer predisposition genes

Cancer genetics, 2017-10, Vol.216-217, p.159-169

2017

Link zum Volltext

Verfügbarkeit prüfen

Increased Identification of Candidates for High-Risk Breast Cancer Screening Through Expanded Genetic Testing

Journal of the American College of Radiology, 2017-04, Vol.14 (4), p.561-568

2017

Link zum Volltext

Verfügbarkeit prüfen

Assessment of in silico protein sequence analysis in the clinical classification of variants in cancer risk genes

Journal of community genetics, 2017-04, Vol.8 (2), p.87-95

2017

Link zum Volltext

Verfügbarkeit prüfen

Hereditary cancer testing in patients with ovarian cancer using a 25-gene panel

The Journal of community and supportive oncology, 2016-07, Vol.14 (7), p.314-319

2016

Link zum Volltext

Verfügbarkeit prüfen

Analytical validation of a proliferation-based molecular signature used as a prognostic marker in early stage lung adenocarcinoma

Biomarkers in medicine, 2015-09, Vol.9 (9), p.901-910

2015

Link zum Volltext

Verfügbarkeit prüfen

Clinical Variant Classification: A Comparison of Public Databases and a Commercial Testing Laboratory

The oncologist (Dayton, Ohio), 2017-07, Vol.22 (7), p.797-803

2017

Link zum Volltext

Verfügbarkeit prüfen

Prediction of Distant Recurrence Using EndoPredict Among Women with ER + , HER2 - Node-Positive and Node-Negative Breast Cancer Treated with Endocrine Therapy Only

Clinical cancer research, 2019-07, Vol.25 (13), p.3865-3872

2019

Link zum Volltext

Verfügbarkeit prüfen

Clinical testing with a panel of 25 genes associated with increased cancer risk results in a significant increase in clinically significant findings across a broad range of cancer histories

Cancer genetics, 2017-12, Vol.218-219, p.58-68

2017

Link zum Volltext

Verfügbarkeit prüfen

Biomarker Assessment of HR Deficiency, Tumor BRCA1/2 Mutations, and CCNE1 Copy Number in Ovarian Cancer: Associations with Clinical Outcome Following Platinum Monotherapy

Molecular cancer research, 2018-07, Vol.16 (7), p.1103-1111

2018

Link zum Volltext

Verfügbarkeit prüfen

The clinical utility of combinatorial pharmacogenomic testing for patients with depression: a meta-analysis

Pharmacogenomics, 2020-06, Vol.21 (8), p.559

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 148

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(140)
Mit Volltextzugriff
(135)

Publikationsform

Sprache

Englisch
(148)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

A study of over 35,000 women with breast cancer tested with a 25‐gene panel of hereditary cancer genes

Prevalence of Variant Reclassification Following Hereditary Cancer Genetic Testing

Impact of pharmacogenomics on clinical outcomes in major depressive disorder in the GUIDED trial: A large, patient- and rater-blinded, randomized, controlled study

An independent validation of a gene expression signature to differentiate malignant melanoma from benign melanocytic nevi

Lipid Flip-Flop in Binary Membranes Composed of Phosphatidylserine and Phosphatidylcholine

Phosphatidylglycerol Flip-Flop Suppression due to Headgroup Charge Repulsion

Electrostatic Induction of Lipid Asymmetry

Phospholipid flip-flop modulated by transmembrane peptides WALP and melittin

The effect of cholesterol on the intrinsic rate of lipid flip-flop as measured by sum-frequency vibrational spectroscopy

Phase II neoadjuvant clinical trial of carboplatin and eribulin in women with triple negative early-stage breast cancer (NCT01372579)

Age of ovarian cancer diagnosis among BRIP1, RAD51C, and RAD51D mutation carriers identified through multi-gene panel testing

Impact of a genetic counseling requirement prior to genetic testing

Detection of somatic variants in peripheral blood lymphocytes using a next generation sequencing multigene pan cancer panel

Detection of large rearrangements in a hereditary pan-cancer panel using next-generation sequencing

Lynch Syndrome Patients with Limited Family History Identified in a Laboratory Setting: A Descriptive Study

Identification of pathogenic retrotransposon insertions in cancer predisposition genes

Increased Identification of Candidates for High-Risk Breast Cancer Screening Through Expanded Genetic Testing

Assessment of in silico protein sequence analysis in the clinical classification of variants in cancer risk genes

Hereditary cancer testing in patients with ovarian cancer using a 25-gene panel

Analytical validation of a proliferation-based molecular signature used as a prognostic marker in early stage lung adenocarcinoma

Clinical Variant Classification: A Comparison of Public Databases and a Commercial Testing Laboratory

Prediction of Distant Recurrence Using EndoPredict Among Women with ER + , HER2 - Node-Positive and Node-Negative Breast Cancer Treated with Endocrine Therapy Only

Clinical testing with a panel of 25 genes associated with increased cancer risk results in a significant increase in clinically significant findings across a broad range of cancer histories

Biomarker Assessment of HR Deficiency, Tumor BRCA1/2 Mutations, and CCNE1 Copy Number in Ovarian Cancer: Associations with Clinical Outcome Following Platinum Monotherapy

The clinical utility of combinatorial pharmacogenomic testing for patients with depression: a meta-analysis

Suchergebnisse filtern